Stuart Tindal, Sartorius, and David Chau, Thermo Fisher, discuss automation, single-use technology limits, and predictive control shaping continuous bioprocessing's future.
Stuart Tindal
Advertisement
Portfolio Manager
Intensified Downstream Systems
Sartorius
Articles by Stuart Tindal
Stuart Tindal and David Chau discuss spectroscopic sensor selection for continuous bioprocessing and how industry collaboration drives shared innovation.
At INTERPHEX 2026, David Chau and Stuart Tindal discuss automation, single-use durability challenges, and the shift to predictive control in continuous bioprocessing.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Renewing Prosaic Generics for Cancer Treatment
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5